TriSalus Life Sciences, Inc.
TLSI
$4.56
$0.020.44%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/19/2025
-
MarketBeat
5/13/2026
-
Seeking Alpha: Transcripts
5/13/2026
-
SeekingAlpha
5/12/2026
-
Benzinga
5/12/2026
-
Zacks Investment Research
5/12/2026
-
Zacks Investment Research
5/12/2026
-
Seeking Alpha - Healthcare
5/12/2026
-
Business Wire
5/12/2026
-
Business Wire
5/10/2026
-
Insider Monkey
5/8/2026
-
Insider Monkey
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/5/2026
-
MarketBeat
5/4/2026
-
Business Wire
4/29/2026
-
TipRanks Financial Blog
4/28/2026
-
Business Wire
4/28/2026
-
TipRanks Financial Blog
4/16/2026
-
MarketBeat
4/9/2026
-
Business Wire
4/7/2026
-
Nasdaq News: Markets
4/7/2026
-
Business Wire
4/1/2026
-
Tickeron - Stocks
3/31/2026
-
Tickeron - Stocks
3/26/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 5, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Apr 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888 321 5212
Address
6272 West 91st Avenue
Westminster, CO 80031
Westminster, CO 80031
Country
Year Founded
Business Description
Sector
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients...
more